In Vivo Model to Assess the Nasal Infection by Minor Group Rhinovirus

Area of Science:

• Virology
• Immunology
• Preclinical Models

Background:

• Rhinovirus (RV) infects humans through nasal epithelial cells, spreading via respiratory droplets.
• Existing research on RV nasal mucosal responses and antiviral drugs in humans is limited and costly.
• Current preclinical models focus on lung inflammation, which may not represent upper respiratory tract infections.

Purpose of the Study:

• To describe a novel mouse model for rhinovirus infection.
• To establish a preclinical model for studying sinonasal inflammation induced by RV.
• To facilitate the evaluation of antiviral drugs for RV infections affecting the upper respiratory tract.

Main Methods:

• Development and characterization of a mouse model for rhinovirus infection.
• Assessment of inflammatory responses within the sinonasal mucosa.
• Observation of viral clearance and resolution of inflammation.

Main Results:

• The mouse model successfully replicates self-limiting inflammation in the sinonasal mucosa following RV infection.
• The model allows for the study of upper respiratory tract responses to rhinovirus.
• Demonstrates the utility of the model for preclinical assessment of antiviral efficacy.

Conclusions:

• The described mouse model provides a valuable preclinical tool for rhinovirus research.
• This model is suitable for investigating antiviral therapies targeting upper respiratory tract infections.
• Facilitates cost-effective evaluation of antiviral drugs before human clinical trials.